176 related articles for article (PubMed ID: 23283838)
21. Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
Zalta AK; Dowd S; Rosenfield D; Smits JA; Otto MW; Simon NM; Meuret AE; Marques L; Hofmann SG; Pollack MH
Depress Anxiety; 2013 Nov; 30(11):1114-20. PubMed ID: 24038728
[TBL] [Abstract][Full Text] [Related]
22. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
[TBL] [Abstract][Full Text] [Related]
23. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
24. A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects.
Watson BJ; Wilson S; Griffin L; Kalk NJ; Taylor LG; Munafò MR; Lingford-Hughes AR; Nutt DJ
Psychopharmacology (Berl); 2011 Jul; 216(1):121-9. PubMed ID: 21318564
[TBL] [Abstract][Full Text] [Related]
25. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
26. Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial.
Kuriyama K; Honma M; Soshi T; Fujii T; Kim Y
Psychopharmacology (Berl); 2011 Dec; 218(3):589-97. PubMed ID: 21594560
[TBL] [Abstract][Full Text] [Related]
27. An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia.
Aupperle RL; Hale LR; Chambers RJ; Cain SE; Barth FX; Sharp SC; Denney DR; Savage CR
CNS Spectr; 2009 Oct; 14(10):556-71. PubMed ID: 20095368
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
[TBL] [Abstract][Full Text] [Related]
29. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
[TBL] [Abstract][Full Text] [Related]
30. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
Davis M; Ressler K; Rothbaum BO; Richardson R
Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
[TBL] [Abstract][Full Text] [Related]
31. Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans.
Kuriyama K; Honma M; Yoshiike T; Kim Y
Neuropharmacology; 2013 Jan; 64():424-31. PubMed ID: 22992332
[TBL] [Abstract][Full Text] [Related]
32. The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals.
Gutner CA; Weinberger J; Hofmann SG
Cogn Behav Ther; 2012; 41(4):335-44. PubMed ID: 22992160
[TBL] [Abstract][Full Text] [Related]
33. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
Scheeringa MS; Weems CF
J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
[TBL] [Abstract][Full Text] [Related]
34. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rück C; Monzani B; Pérez-Vigil A; Frumento P; Davis M; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner CA; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P; Turner C; Otto MW
J Anxiety Disord; 2019 Dec; 68():102149. PubMed ID: 31698111
[TBL] [Abstract][Full Text] [Related]
35. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
Otto MW; Kredlow MA; Smits JAJ; Hofmann SG; Tolin DF; de Kleine RA; van Minnen A; Evins AE; Pollack MH
Biol Psychiatry; 2016 Aug; 80(4):274-283. PubMed ID: 26520240
[TBL] [Abstract][Full Text] [Related]
37. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders.
Rapee RM; Jones MP; Hudson JL; Malhi GS; Lyneham HJ; Schneider SC
Behav Res Ther; 2016 Dec; 87():225-231. PubMed ID: 27771572
[TBL] [Abstract][Full Text] [Related]
38. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
39. No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
Hofmeijer-Sevink MK; Duits P; Rijkeboer MM; Hoogendoorn AW; van Megen HJ; Vulink NC; Denys DA; van den Hout MA; van Balkom AJ; Cath DC
J Clin Psychopharmacol; 2017 Oct; 37(5):531-539. PubMed ID: 28820746
[TBL] [Abstract][Full Text] [Related]
40. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
